We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Healthcare Inv | LSE:HIO | London | Ordinary Share | GB00B94T6Y14 | ORD 1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 14.75 | 0.00 | 00:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 14.75 | GBX |
Healthcare Inv (HIO) Share Charts1 Year Healthcare Inv Chart |
|
1 Month Healthcare Inv Chart |
Intraday Healthcare Inv Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 05/1/2014 | 15:53 | Healthcare from Evans | 26 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 05/1/2014 15:53 by cnx HIO now moved to COS |
Posted at 30/12/2013 14:29 by doodlebug4 From an article in the Daily Mail published 31st July. Flotation was in April."At the time of HIO's flotation Evans was granted options over 4.05million shares (10 per cent of the equity), which will only vest in the event that an acquisition is completed within 12 months from admission, and if the share price is in excess of 20p per share. Once vested, the exercise period of the options will be 10 years and the exercise price will be 10p per share. Evans has a big City fan club and it is easy to see why. The companies under his stewardship have a strong record of value generation for shareholders. He was chief executive of Shield Diagnostics prior to the merger with Axis Biochemicals to form Axis Shield in 1999. He was also chairman of Immunodiagnostic Systems, which floated in December 2004 at 51p and was trading at 1046p at the time he left the company in September 2011." |
Posted at 27/12/2013 15:32 by doodlebug4 Director ShareholdingRNS RNS Number : 4668W Healthcare Investment Opportunities 27 December 2013 27 December 2013 Healthcare Investment Opportunities Plc (the "Company") Director Shareholding Healthcare Investment Opportunities plc (AIM: HIO), an investment company focusing on the healthcare sector, announces that today Malcolm Gillies, a Director of Healthcare Investment Opportunities, has purchased a total of 250,000 ordinary shares at an average price of 12.789 pence per share. This brings Malcolm Gillies' interest in the Company's current issued share capital to 500,000 being 1.24% of the current issued share capital. |
Posted at 31/7/2013 16:02 by doodlebug4 Delayed trades put through this afternoon, I suppose some of the people who bought in at the original float price in April might be happy to cash in on their profit. I'm happy to wait this one out, even if it takes 7 years for David Evans to put in a similar performance to the one when he was chairman of Immundiagnostic Systems ! |
Posted at 31/7/2013 14:09 by doodlebug4 Buyers paying the full offer price of 17p now. |
Posted at 31/7/2013 07:45 by tpinvest Looks like Mail readers are having a lie-in this morning.No reaction to this news so far; Rumours yesterday suggested David Evans is about to set pulses racing in the AIM market again. Shares of his cash shell Healthcare Investment Opportunities (HIO) touched 16.9p before closing 0.88p or 5.6 per cent up at a record 16.5p on hot gossip of an imminent transformational acquisition. |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
